FOR IMMEDIATE RELEASE
949-777-6112 ext 101
IRVINE, Calif., Dec. 21, 2015 – Praxsyn Corporation (OTCQB:PXYN), a diversified holding company that finds alternative solutions to fit the needs and goals of their strategic relationships, announced that it has appointed James Bradford to its Board of Directors. Bradford also sits on the Board of Products for Doctors, Inc.
“James is an excellent addition to our Board as his experience and leadership in sales, finance and equities will be invaluable,” said Edward Kurtz, CEO of Praxsyn. “We look forward to tapping his expertise in building best practices within our organization.”
Mr. Bradford is an executive partner and founder of Products for Doctors, Inc. Prior to founding Products for Doctors, he was the president and founder of TK Carsites. Bradford’s in-depth investment experience in commodities trading and private equity was garnered through his positions as an investment strategist at Manufacturers Asset Group, a regional sales manager at John James Investment, and a national sales manager at Hampton Group.
Bradford’s extensive experience includes sales management, marketing, software and service in B2B markets; product and channel development; cultivation of partnerships; acquisitions and private equity fund raising. He has held series 3 and 63 financial securities licenses, traded on the CBOT/CME and Forex, and specialized in trading securities, bonds and currencies.
About Praxsyn Corporation and Subsidiaries
Headquartered in Irvine, California, Praxsyn is a holding company who finds alternative solutions that prioritize the needs and goals of their strategic relationships. Mesa Pharmacy Inc., is a wholly owned subsidiary and a community retail pharmacy who provides custom medications that are marketed to health physicians and medical clinics. NexGen Med Solutions LLC is a wholly owned subsidiary who specializes in the billing and collections of worker’s compensation claims. Additional company information can be found at www.praxsyn.com.
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.